US FDA approves Noven’s schizophrenia treatment administered through a once-daily transdermal delivery system, able to release the antipsychotic drug for 24 hours.
MedPharm expands its US Center of Excellence in Durham, North Carolina, in response to increasing demand for its topical and transdermal formulation development, and performance testing services.
Transdermal drug delivery expert Noven Pharmaceuticals is to buy
JDS Pharmaceuticals in a deal worth $125m (€91m) to transform
itself into a 'fully-integrated speciality pharmaceutical company'.
A novel drug delivery system that allows hospital patients to
self-administer pain relief medication without an intravenous line
could be available in the US within six months, pending final Food
and Drug Administration (FDA) approval.
A group of US researchers claim to have identified a fundamental
mechanism that may facilitate the design of safer and more
efficacious topical drug delivery systems, reports Phil
Taylor.
The launch of newer technology products with a wide range of
applications and the facility to deliver proteins, peptides, and
large molecules is expected to rake in market revenues, according
to a new report from market analysts Frost...